Background
Bacterial gastroenteritis is a very common disorder. It has many causes, can range from mild to severe, and usually manifests with symptoms of vomiting, diarrhea, and abdominal discomfort. Other causes of some of these symptoms include viral infections, improper diet, malabsorption syndromes, various enteropathies, and inflammatory bowel disease. Bacterial gastroenteritis is usually self-limited, but improper management of an acute infection can lead to a protracted course. By far, the most common complication is dehydration.[1, 2, 3, 4]
For excellent patient education resources, visit eMedicine's Esophagus, Stomach, and Intestine Center and Public Health Center. Also, see eMedicine's patient education articles Gastroenteritis and Foreign Travel.
Pathophysiology
Bacteria employ several mechanisms to invoke a pathologic response. Invasive bacteria cause mucosal ulceration and abscess formation with a subsequent inflammatory cascade. Bacterial toxins control enteral and extraenteral cellular processes. For example, the heat-labile and heat-stable enterotoxins of Escherichia coli activate enteral adenylate cyclase and guanylate cyclase.
Verotoxin, which enterohemorrhagic E coli and Shigella species produce, causes systemic disorders such as seizures and hemolytic-uremic syndrome (HUS). Other noninvasive bacteria adhere to the gut wall, causing inflammation. Organisms such as E coli and Clostridium species are normal enteric flora, pathogenic strains of which can cause gastroenteritis.
Epidemiology
Frequency
United States
Bacterial gastroenteritis is a very common problem in primary care and emergency department settings, especially for children younger than 5 years.[3, 4] Diarrhea accounts for as many as 5% of pediatric office visits and 10% of hospitalizations in this age group. Very often, gastroenteritis is underreported in the adult population.
Each year, gastroenteritis affects adults and accounts for 8 million doctor visits and 250,000 hospitalizations. Episodes of gastroenteritis do not occur at random but usually occur in outbreaks. Traveler's diarrhea affects 20-50% of people traveling from industrialized to developing countries.[4, 5, 6]
International
Worldwide, millions of children and adults are affected by diarrhea each year. In developing countries, where sanitation is suboptimal, epidemics of bacterial gastroenteritis can develop and cause significant mortality.[2, 4, 5, 6, 7]
Mortality/Morbidity
Diarrhea and vomiting are so commonplace that nonphysicians usually underappreciate the potential mortality and morbidity of bacterial gastroenteritis. In the United States each year, several hundred people die from complications of bacterial gastroenteritis; the majority are elderly people.
Many developing countries do not have the resources to properly treat diarrhea and vomiting associated with bacterial gastroenteritis, leading to a disproportionately high mortality rate. Gastroenteritis-causing pathogens are the second leading cause of morbidity and mortality worldwide.
Race
It has been reported that the preparation and ingestion of chitterlings, common among some blacks, especially during the holiday season, may pose an increased risk of infection with Yersinia enterocolitica serotype O:3.[8, 9]
Sex
Most infectious diarrheas do not affect one sex more than the other; however, females have a higher incidence of Campylobacter infections and hemolytic-uremic syndrome (HUS).
Age
Yersinia species infect children younger than 1 year almost exclusively, and Aeromonas species are a significant cause of bacterial gastroenteritis in young children. Very young children are particularly susceptible to secondary dehydration and malabsorption.
Salminen S, Isolauri E, Onnela T. Gut flora in normal and disordered states. Chemotherapy. 1995;41 suppl 1:5-15. [Medline].
Marks MI. Infectious diarrhea: introduction and commentary. Pediatr Ann. Oct 1994;23(10):526-7. [Medline].
Liebelt EL. Clinical and laboratory evaluation and management of children with vomiting, diarrhea, and dehydration. Curr Opin Pediatr. Oct 1998;10(5):461-9. [Medline].
Hamer DH, Gorbach SL. Infectious diarrhea and bacterial food poisoning. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisinger and Fordtran's Gastrointestinaland Liver Disease. 6th ed. Philadelphia, Pa: WB Saunders; 1998:1594-1632.
Steffen R, Collard F, Tornieporth N, et al. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA. Mar 3 1999;281(9):811-7. [Medline]. [Full Text].
Streit JM, Jones RN, Toleman MA, Stratchounski LS, Fritsche TR. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents. May 2006;27(5):367-75. [Medline].
World Health Organization. Cholera: fact sheet no. 107. November 2008. Available at http://www.who.int/mediacentre/factsheets/fs107/en/. Accessed February 19, 2009.
Lee LA, Gerber AR, Lonsway DR, et al. Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings. N Engl J Med. Apr 5 1990;322(14):984-7. [Medline].
Centers for Disease Control and Prevention. Yersinia enterocolitica. October 25, 2005. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/yersinia_g.htm. Accessed February 18, 2009.
Calbo E, Freixas N, Xercavins M, Riera M, Nicolás C, Monistrol O, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis. Mar 2011;52(6):743-9. [Medline].
Cody SH, Abbott SL, Marfin AA, et al. Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northern California. JAMA. May 19 1999;281(19):1805-10. [Medline]. [Full Text].
World Health Organization. Drug-resistant Salmonella: fact sheet no. 139. Revised April 2005. Available at http://www.who.int/mediacentre/factsheets/fs139/en/. Accessed February 19, 2009.
Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. Jan 2000;30(1):54-60. [Medline].
Simakachorn N, Pichaipat V, Rithipornpaisarn P, et al. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr. Jan 2000;30(1):68-72. [Medline].
Duggan C, Nurko S. "Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea. J Pediatr. Dec 1997;131(6):801-8. [Medline].
Guandalini S, Dincer AP. Nutritional management in diarrhoeal disease. Baillieres Clin Gastroenterol. Dec 1998;12(4):697-717. [Medline].
Sullivan PB. Nutritional management of acute diarrhea. Nutrition. Oct 1998;14(10):758-62. [Medline].
[Best Evidence] Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al, for the Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. Jan 5 2006;354(1):11-22. [Medline]. [Full Text].
Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. May 2006;130(6):1588-94. [Medline].
Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm. Nov 15 2007;64(22):2359-63. [Medline].
DuPont HL, The Practice Parameters Committee of the American College of Gastroenterology. Guidelines on acute infectious diarrhea in adults. Am J Gastroenterol. Nov 1997;92(11):1962-75. [Medline].
Garcia Rodriguez LA, Ruigomez A, Panes J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol. Dec 2007;5(12):1418-23. [Medline].
Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother. Aug 2006;58(2):243-55. [Medline]. [Full Text].
Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. Microbiol Immunol. 2007;51(12):1209-14. [Medline]. [Full Text].
Mines D, Stahmer S, Shepherd SM. Poisonings: food, fish, shellfish. Emerg Med Clin North Am. Feb 1997;15(1):157-77. [Medline].
Nataro JP, Steiner T, Guerrant RL. Enteroaggregative Escherichia coli. Emerg Infect Dis. Apr-Jun 1998;4(2):251-61. [Medline].
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med. Jun 2006;119(6 suppl 1):S20-8; discussion S62-70. [Medline].
Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. Feb 27 1999;318(7183):565-6. [Medline]. [Full Text].
Trachtman H, Christen E. Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome. Curr Opin Pediatr. Apr 1999;11(2):162-8. [Medline].
Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. Jun 29 2000;342(26):1930-6. [Medline]. [Full Text].
| Stool Characteristics | Small Bowel | Large Bowel |
| Appearance | Watery | Mucus and/or blood |
| Volume | Large | Small |
| Frequency | Increased | Increased |
| Blood | Possibly heme-positive but never gross blood | Possibly grossly bloody |
| pH | Possibly < 5.5 | >5.5 |
| Reducing Substances | Possibly positive | Negative |
| WBC count | < 5/HPF | Possibly >10/HPF |
| Serum WBC count | Normal | Possible leukocytosis, bandemia |
| Organisms | Preformed toxins: Bacillus species, Staphylococcus aureus | Invasive bacteria: E coli and Shigella, Salmonella, Campylobacter, Yersinia, Aeromonas, and Plesiomonas species |
| Toxic bacteria: E coli, cholera, C perfringens, Vibrio species, Listeria monocytogenes | Toxic bacteria: C difficile | |
| Other causes: Rotavirus, Adenovirus, Calicivirus, Astrovirus, Norwalk virus, Giardia and Cryptosporidium species | Other causes: Entamoeba species |
| Organism | Incubation | Duration | Vomiting | Fever | Abdominal Pain |
| Aeromonas species | None | 0-2 weeks | +/- | +/- | No |
| Bacillus species | 1-16 hours | 1-2 days | Yes | No | Yes |
| Campylobacter species | 2-4 days | 5-7 days | No | Yes | Yes |
| C difficile | Variable | Variable | No | Few | Few |
| C perfringens | 0-1 | 1 day | Mild | No | Yes |
| Enterohemorrhagic E coli | 1-8 days | 3-6 days | No | +/- | Yes |
| Enterotoxigenic E coli | 1-3 days | 3-5 days | Yes | Low | Yes |
| Listeria species | 20 hours | 2 days | Few | Yes | +/- |
| Plesiomonas species | None | 0-2 weeks | +/- | +/- | +/- |
| Salmonella species | 0-3 days | 2-7 days | Yes | Yes | Yes |
| Shigella species | 0-2 days | 2-7 days | No | High | Yes |
| S aureus | 2-6 hours | 1 day | Yes | No | Yes |
| Vibrio species | 0-1 days | 5-7 days | Yes | No | Yes |
| Y enterocolitica | 0-6 | 1-46 days | Yes | Yes | Yes |
| Organism | Detection Method | Microbiological Characteristics |
| Aeromonas species | Blood agar | Oxidase-positive, flagellated GNB |
| Bacillus species | Blood agar | Facultatively aerobic, spore-forming GPR; beta-hemolytic; reduces nitrates; ferments carbohydrates |
| Campylobacter species | Skirrow agar | Rapidly motile, curved GNR; Campylobacter jejuni 90% of infections, Campylobacter coli 5% of infections |
| C difficile | CCFE agar, EIA for toxin, LA for protein | Anaerobic, spore-forming GPR; toxin-mediated diarrhea; produces pseudomembranous colitis |
| C perfringens | None available | Anaerobic, spore-forming GPR; toxin-mediated diarrhea |
| E coli | MacConkey, EMB, or SM agar | Lactose-producing GNR |
| Listeria species | Blood agar | Flagellated GPB |
| Plesiomonas species | Blood agar | Oxidase-positive GNR |
| Salmonella species | Blood, MacConkey, EMB, XLD, or HE agar | Nonlactose, non–H2S-producing GNR |
| Shigella species | Blood, MacConkey, EMB, XLD, or HE agar | Nonlactose and H2S-producing GNR; verotoxin (neurotoxin) |
| Staphylococcus species | Blood agar | Heat-stable, preformed toxin-mediated GPC |
| Vibrio species | Blood or TCBS agar | Oxidase-positive, motile, curved GNB |
| Y enterocolitica | CIN agar | Nonlactose-producing, oval GNR |

